Vaxigrip Tetra

On 10 April 2022 the Australian Government assumed a caretaker role. The Government is now operating in accordance with the Caretaker Conventions, pending the outcome of the 2022 federal election. See Information on Caretaker Conventions. On 10 April 2022 the Australian Government assumed a caretaker role. The Government is now operating in accordance with the Caretaker Conventions, pending the outcome of the 2022 federal election. See Information on Caretaker Conventions.

Listen

Sponsor:

Sanofi-Aventis Australia

Administration route:

Intramuscular injection, Subcutaneous injection

Vaccine group:

All people aged ≥6 months

Registered for use in people aged ≥6 months.

Quadrivalent inactivated influenza vaccine

Each 0.5 mL monodose pre-filled syringe contains:

15 µg haemagglutinin of each of the 4 recommended influenza virus strains

Also contains traces of:

ovalbumin (≤ 0.05 µg)
neomycin (≤ 10.1 pg)
formaldehyde (≤ 30 µg)
octoxinol-9 (≤ 222.5 µg)

Page history

Last updated:

9 April 2020

Last reviewed:

9 April 2020

Is there anything wrong with this page?

All vaccines

Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/vaxigrip-tetra.

Page history

Share this